Public engagement and clinical trials :: new models and disruptive technologies : workshop summary /
"Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognit...
Gespeichert in:
| Körperschaften: | , |
|---|---|
| Weitere Verfasser: | , , |
| Format: | Elektronisch Tagungsbericht E-Book |
| Sprache: | English |
| Veröffentlicht: |
Washington, D.C. :
National Academies Press,
2011.
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Zusammenfassung: | "Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials"--Publisher's description. |
| Beschreibung: | 1 online resource (xvi, 124 pages :) |
| Bibliographie: | Includes bibliographical references (pages 85-87). |
| ISBN: | 9780309219297 0309219299 9780309219303 0309219302 |
Internformat
MARC
| LEADER | 00000cam a2200000 a 4500 | ||
|---|---|---|---|
| 001 | ZDB-4-EBA-ocn769188485 | ||
| 003 | OCoLC | ||
| 005 | 20240705115654.0 | ||
| 006 | m o d | ||
| 007 | cr cn||||||||| | ||
| 008 | 111205s2011 dcua ob 100 0 eng d | ||
| 040 | |a E7B |b eng |e pn |c E7B |d IDEBK |d N$T |d MMU |d YDXCP |d TPH |d OCLCQ |d CDX |d UCNAP |d ZMC |d OCLCQ |d OCLCA |d OCLCF |d NLGGC |d COO |d OCLCQ |d VT2 |d OCLCQ |d AGLDB |d TOA |d MOR |d OCLCO |d PIFAG |d OCLCQ |d OCLCA |d BUF |d OCLCO |d STF |d VNS |d WRM |d VTS |d NRAMU |d EZ9 |d ICG |d MERER |d REC |d AU@ |d OCLCQ |d OCLCO |d LVT |d M8D |d OCLCQ |d OCLCO |d OCLCA |d UKCRE |d AJS |d OCLCO |d OCLCQ |d OCL |d OCLCO |d OCLCQ |d OCLCL | ||
| 016 | 7 | |a 101582836 |2 DNLM | |
| 016 | 7 | |a 016066521 |2 Uk | |
| 019 | |a 760055026 |a 772459094 |a 971092635 |a 988460703 |a 991919289 |a 1037929686 |a 1038664408 |a 1045551101 |a 1047527785 |a 1058168116 |a 1153534888 | ||
| 020 | |a 9780309219297 |q (e-book) | ||
| 020 | |a 0309219299 |q (e-book) | ||
| 020 | |a 9780309219303 |q (electronic bk.) | ||
| 020 | |a 0309219302 |q (electronic bk.) | ||
| 020 | |z 0309219299 | ||
| 035 | |a (OCoLC)769188485 |z (OCoLC)760055026 |z (OCoLC)772459094 |z (OCoLC)971092635 |z (OCoLC)988460703 |z (OCoLC)991919289 |z (OCoLC)1037929686 |z (OCoLC)1038664408 |z (OCoLC)1045551101 |z (OCoLC)1047527785 |z (OCoLC)1058168116 |z (OCoLC)1153534888 | ||
| 043 | |a n-us--- | ||
| 050 | 4 | |a R853.C55 |b P83 2011eb | |
| 060 | 4 | |a QV 771 | |
| 072 | 7 | |a MED |x 047000 |2 bisacsh | |
| 082 | 7 | |a 610.724 |2 23 | |
| 049 | |a MAIN | ||
| 111 | 2 | |a Public Engagement and Clinical Trials: New Models and Disruptive Technologies |d (2011 : |c Mount Sinai School of Medicine) |0 http://id.loc.gov/authorities/names/no2012029643 | |
| 245 | 1 | 0 | |a Public engagement and clinical trials : |b new models and disruptive technologies : workshop summary / |c Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| 260 | |a Washington, D.C. : |b National Academies Press, |c 2011. | ||
| 300 | |a 1 online resource (xvi, 124 pages :) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 504 | |a Includes bibliographical references (pages 85-87). | ||
| 520 | |a "Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials"--Publisher's description. | ||
| 505 | 0 | 0 | |t Introduction -- |t Framing the problem -- |t Recruitment challenges in clinical trials for different diseases and conditions -- |t Models for public health engagement -- |t The media -- |t Novel clinical trial designs -- |t The health system's structure and culture -- |t Toward a patient-centered strategy for clinical trials. |
| 650 | 0 | |a Clinical trials. |0 http://id.loc.gov/authorities/subjects/sh85027069 | |
| 650 | 0 | |a Patient participation. |0 http://id.loc.gov/authorities/subjects/sh97002539 | |
| 650 | 0 | |a Patient education. |0 http://id.loc.gov/authorities/subjects/sh85098703 | |
| 650 | 1 | 2 | |a Clinical Trials as Topic |
| 650 | 1 | 2 | |a Patient Participation |
| 650 | 2 | 2 | |a Drug Evaluation |
| 650 | 2 | 2 | |a Patient Education as Topic |
| 651 | 2 | |a United States | |
| 650 | 6 | |a Études cliniques. | |
| 650 | 6 | |a Participation des patients. | |
| 650 | 6 | |a Éducation des patients. | |
| 650 | 7 | |a MEDICAL |x Laboratory Medicine. |2 bisacsh | |
| 650 | 7 | |a Patient participation |2 fast | |
| 650 | 7 | |a Patient education |2 fast | |
| 650 | 7 | |a Clinical trials |2 fast | |
| 655 | 4 | |a Electronic resource. | |
| 700 | 1 | |a Weisfeld, Victoria D. |0 http://id.loc.gov/authorities/names/n89630070 | |
| 700 | 1 | |a English, Rebecca A. |0 http://id.loc.gov/authorities/names/no2010177259 | |
| 700 | 1 | |a Claiborne, Anne B. |0 http://id.loc.gov/authorities/names/no2011029945 | |
| 710 | 2 | |a Institute of Medicine (U.S.). |b Forum on Drug Discovery, Development, and Translation. |0 http://id.loc.gov/authorities/names/no2007051854 | |
| 758 | |i has work: |a Public engagement and clinical trials (Text) |1 https://id.oclc.org/worldcat/entity/E39PCFPdghJFG9MDDtWV4ytqHy |4 https://id.oclc.org/worldcat/ontology/hasWork | ||
| 776 | 0 | 8 | |i Print version: |t Public Engagement and Clinical Trials. |d Washington, D.C. : National Academies Press, ©2011 |z 9780309219297 |w (OCoLC)767570602 |
| 856 | 1 | |l FWS01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=400080 |3 Volltext | |
| 856 | 1 | |l CBO01 |p ZDB-4-EBA |q FWS_PDA_EBA |u https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=400080 |3 Volltext | |
| 938 | |a Coutts Information Services |b COUT |n 19873040 | ||
| 938 | |a ebrary |b EBRY |n ebr10506513 | ||
| 938 | |a EBSCOhost |b EBSC |n 400080 | ||
| 938 | |a ProQuest MyiLibrary Digital eBook Collection |b IDEB |n 331196 | ||
| 938 | |a YBP Library Services |b YANK |n 7365280 | ||
| 994 | |a 92 |b GEBAY | ||
| 912 | |a ZDB-4-EBA | ||
Datensatz im Suchindex
| DE-BY-FWS_katkey | ZDB-4-EBA-ocn769188485 |
|---|---|
| _version_ | 1813903421496885248 |
| adam_text | |
| any_adam_object | |
| author2 | Weisfeld, Victoria D. English, Rebecca A. Claiborne, Anne B. |
| author2_role | |
| author2_variant | v d w vd vdw r a e ra rae a b c ab abc |
| author_GND | http://id.loc.gov/authorities/names/n89630070 http://id.loc.gov/authorities/names/no2010177259 http://id.loc.gov/authorities/names/no2011029945 |
| author_corporate | Public Engagement and Clinical Trials: New Models and Disruptive Technologies Mount Sinai School of Medicine Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation |
| author_corporate_role | |
| author_facet | Weisfeld, Victoria D. English, Rebecca A. Claiborne, Anne B. Public Engagement and Clinical Trials: New Models and Disruptive Technologies Mount Sinai School of Medicine Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation |
| author_sort | Public Engagement and Clinical Trials: New Models and Disruptive Technologies Mount Sinai School of Medicine |
| building | Verbundindex |
| bvnumber | localFWS |
| callnumber-first | R - Medicine |
| callnumber-label | R853 |
| callnumber-raw | R853.C55 P83 2011eb |
| callnumber-search | R853.C55 P83 2011eb |
| callnumber-sort | R 3853 C55 P83 42011EB |
| callnumber-subject | R - General Medicine |
| collection | ZDB-4-EBA |
| contents | Introduction -- Framing the problem -- Recruitment challenges in clinical trials for different diseases and conditions -- Models for public health engagement -- The media -- Novel clinical trial designs -- The health system's structure and culture -- Toward a patient-centered strategy for clinical trials. |
| ctrlnum | (OCoLC)769188485 |
| dewey-full | 610.724 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 610 - Medicine and health |
| dewey-raw | 610.724 |
| dewey-search | 610.724 |
| dewey-sort | 3610.724 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic Conference Proceeding eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05136cam a2200757 a 4500</leader><controlfield tag="001">ZDB-4-EBA-ocn769188485</controlfield><controlfield tag="003">OCoLC</controlfield><controlfield tag="005">20240705115654.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr cn|||||||||</controlfield><controlfield tag="008">111205s2011 dcua ob 100 0 eng d</controlfield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">E7B</subfield><subfield code="b">eng</subfield><subfield code="e">pn</subfield><subfield code="c">E7B</subfield><subfield code="d">IDEBK</subfield><subfield code="d">N$T</subfield><subfield code="d">MMU</subfield><subfield code="d">YDXCP</subfield><subfield code="d">TPH</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">CDX</subfield><subfield code="d">UCNAP</subfield><subfield code="d">ZMC</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">OCLCF</subfield><subfield code="d">NLGGC</subfield><subfield code="d">COO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">VT2</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">AGLDB</subfield><subfield code="d">TOA</subfield><subfield code="d">MOR</subfield><subfield code="d">OCLCO</subfield><subfield code="d">PIFAG</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCA</subfield><subfield code="d">BUF</subfield><subfield code="d">OCLCO</subfield><subfield code="d">STF</subfield><subfield code="d">VNS</subfield><subfield code="d">WRM</subfield><subfield code="d">VTS</subfield><subfield code="d">NRAMU</subfield><subfield code="d">EZ9</subfield><subfield code="d">ICG</subfield><subfield code="d">MERER</subfield><subfield code="d">REC</subfield><subfield code="d">AU@</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">LVT</subfield><subfield code="d">M8D</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCA</subfield><subfield code="d">UKCRE</subfield><subfield code="d">AJS</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCL</subfield><subfield code="d">OCLCO</subfield><subfield code="d">OCLCQ</subfield><subfield code="d">OCLCL</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">101582836</subfield><subfield code="2">DNLM</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">016066521</subfield><subfield code="2">Uk</subfield></datafield><datafield tag="019" ind1=" " ind2=" "><subfield code="a">760055026</subfield><subfield code="a">772459094</subfield><subfield code="a">971092635</subfield><subfield code="a">988460703</subfield><subfield code="a">991919289</subfield><subfield code="a">1037929686</subfield><subfield code="a">1038664408</subfield><subfield code="a">1045551101</subfield><subfield code="a">1047527785</subfield><subfield code="a">1058168116</subfield><subfield code="a">1153534888</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309219297</subfield><subfield code="q">(e-book)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309219299</subfield><subfield code="q">(e-book)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780309219303</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0309219302</subfield><subfield code="q">(electronic bk.)</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="z">0309219299</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)769188485</subfield><subfield code="z">(OCoLC)760055026</subfield><subfield code="z">(OCoLC)772459094</subfield><subfield code="z">(OCoLC)971092635</subfield><subfield code="z">(OCoLC)988460703</subfield><subfield code="z">(OCoLC)991919289</subfield><subfield code="z">(OCoLC)1037929686</subfield><subfield code="z">(OCoLC)1038664408</subfield><subfield code="z">(OCoLC)1045551101</subfield><subfield code="z">(OCoLC)1047527785</subfield><subfield code="z">(OCoLC)1058168116</subfield><subfield code="z">(OCoLC)1153534888</subfield></datafield><datafield tag="043" ind1=" " ind2=" "><subfield code="a">n-us---</subfield></datafield><datafield tag="050" ind1=" " ind2="4"><subfield code="a">R853.C55</subfield><subfield code="b">P83 2011eb</subfield></datafield><datafield tag="060" ind1=" " ind2="4"><subfield code="a">QV 771</subfield></datafield><datafield tag="072" ind1=" " ind2="7"><subfield code="a">MED</subfield><subfield code="x">047000</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="082" ind1="7" ind2=" "><subfield code="a">610.724</subfield><subfield code="2">23</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">MAIN</subfield></datafield><datafield tag="111" ind1="2" ind2=" "><subfield code="a">Public Engagement and Clinical Trials: New Models and Disruptive Technologies</subfield><subfield code="d">(2011 :</subfield><subfield code="c">Mount Sinai School of Medicine)</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2012029643</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Public engagement and clinical trials :</subfield><subfield code="b">new models and disruptive technologies : workshop summary /</subfield><subfield code="c">Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies.</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Washington, D.C. :</subfield><subfield code="b">National Academies Press,</subfield><subfield code="c">2011.</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 online resource (xvi, 124 pages :)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="504" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references (pages 85-87).</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">"Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials"--Publisher's description.</subfield></datafield><datafield tag="505" ind1="0" ind2="0"><subfield code="t">Introduction --</subfield><subfield code="t">Framing the problem --</subfield><subfield code="t">Recruitment challenges in clinical trials for different diseases and conditions --</subfield><subfield code="t">Models for public health engagement --</subfield><subfield code="t">The media --</subfield><subfield code="t">Novel clinical trial designs --</subfield><subfield code="t">The health system's structure and culture --</subfield><subfield code="t">Toward a patient-centered strategy for clinical trials.</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Clinical trials.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85027069</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Patient participation.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh97002539</subfield></datafield><datafield tag="650" ind1=" " ind2="0"><subfield code="a">Patient education.</subfield><subfield code="0">http://id.loc.gov/authorities/subjects/sh85098703</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Clinical Trials as Topic</subfield></datafield><datafield tag="650" ind1="1" ind2="2"><subfield code="a">Patient Participation</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Drug Evaluation</subfield></datafield><datafield tag="650" ind1="2" ind2="2"><subfield code="a">Patient Education as Topic</subfield></datafield><datafield tag="651" ind1=" " ind2="2"><subfield code="a">United States</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Études cliniques.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Participation des patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="6"><subfield code="a">Éducation des patients.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL</subfield><subfield code="x">Laboratory Medicine.</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Patient participation</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Patient education</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Clinical trials</subfield><subfield code="2">fast</subfield></datafield><datafield tag="655" ind1=" " ind2="4"><subfield code="a">Electronic resource.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weisfeld, Victoria D.</subfield><subfield code="0">http://id.loc.gov/authorities/names/n89630070</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">English, Rebecca A.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2010177259</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Claiborne, Anne B.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2011029945</subfield></datafield><datafield tag="710" ind1="2" ind2=" "><subfield code="a">Institute of Medicine (U.S.).</subfield><subfield code="b">Forum on Drug Discovery, Development, and Translation.</subfield><subfield code="0">http://id.loc.gov/authorities/names/no2007051854</subfield></datafield><datafield tag="758" ind1=" " ind2=" "><subfield code="i">has work:</subfield><subfield code="a">Public engagement and clinical trials (Text)</subfield><subfield code="1">https://id.oclc.org/worldcat/entity/E39PCFPdghJFG9MDDtWV4ytqHy</subfield><subfield code="4">https://id.oclc.org/worldcat/ontology/hasWork</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Print version:</subfield><subfield code="t">Public Engagement and Clinical Trials.</subfield><subfield code="d">Washington, D.C. : National Academies Press, ©2011</subfield><subfield code="z">9780309219297</subfield><subfield code="w">(OCoLC)767570602</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">FWS01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=400080</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="856" ind1="1" ind2=" "><subfield code="l">CBO01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FWS_PDA_EBA</subfield><subfield code="u">https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=400080</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">Coutts Information Services</subfield><subfield code="b">COUT</subfield><subfield code="n">19873040</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ebrary</subfield><subfield code="b">EBRY</subfield><subfield code="n">ebr10506513</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">EBSCOhost</subfield><subfield code="b">EBSC</subfield><subfield code="n">400080</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">ProQuest MyiLibrary Digital eBook Collection</subfield><subfield code="b">IDEB</subfield><subfield code="n">331196</subfield></datafield><datafield tag="938" ind1=" " ind2=" "><subfield code="a">YBP Library Services</subfield><subfield code="b">YANK</subfield><subfield code="n">7365280</subfield></datafield><datafield tag="994" ind1=" " ind2=" "><subfield code="a">92</subfield><subfield code="b">GEBAY</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield></record></collection> |
| genre | Electronic resource. |
| genre_facet | Electronic resource. |
| geographic | United States |
| geographic_facet | United States |
| id | ZDB-4-EBA-ocn769188485 |
| illustrated | Illustrated |
| indexdate | 2024-10-25T16:18:25Z |
| institution | BVB |
| institution_GND | http://id.loc.gov/authorities/names/no2012029643 http://id.loc.gov/authorities/names/no2007051854 |
| isbn | 9780309219297 0309219299 9780309219303 0309219302 |
| language | English |
| oclc_num | 769188485 |
| open_access_boolean | |
| owner | MAIN |
| owner_facet | MAIN |
| physical | 1 online resource (xvi, 124 pages :) |
| psigel | ZDB-4-EBA |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | National Academies Press, |
| record_format | marc |
| spelling | Public Engagement and Clinical Trials: New Models and Disruptive Technologies (2011 : Mount Sinai School of Medicine) http://id.loc.gov/authorities/names/no2012029643 Public engagement and clinical trials : new models and disruptive technologies : workshop summary / Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. Washington, D.C. : National Academies Press, 2011. 1 online resource (xvi, 124 pages :) text txt rdacontent computer c rdamedia online resource cr rdacarrier Includes bibliographical references (pages 85-87). "Clinical trials provide essential information needed to turn basic medical research findings into patient treatments. New treatments must be studied in large numbers of humans to find out whether they are effective and to assess any harm that may arise from treatment. There is growing recognition among many stakeholders that the U.S. clinical trials enterprise is unable to keep pace with the national demand for research results. The IOM, along with the Mount Sinai School of Medicine, held a workshop June 27-28, 2011, to engage stakeholders and experts in a discussion about possible solutions to improve public engagement in clinical trials"--Publisher's description. Introduction -- Framing the problem -- Recruitment challenges in clinical trials for different diseases and conditions -- Models for public health engagement -- The media -- Novel clinical trial designs -- The health system's structure and culture -- Toward a patient-centered strategy for clinical trials. Clinical trials. http://id.loc.gov/authorities/subjects/sh85027069 Patient participation. http://id.loc.gov/authorities/subjects/sh97002539 Patient education. http://id.loc.gov/authorities/subjects/sh85098703 Clinical Trials as Topic Patient Participation Drug Evaluation Patient Education as Topic United States Études cliniques. Participation des patients. Éducation des patients. MEDICAL Laboratory Medicine. bisacsh Patient participation fast Patient education fast Clinical trials fast Electronic resource. Weisfeld, Victoria D. http://id.loc.gov/authorities/names/n89630070 English, Rebecca A. http://id.loc.gov/authorities/names/no2010177259 Claiborne, Anne B. http://id.loc.gov/authorities/names/no2011029945 Institute of Medicine (U.S.). Forum on Drug Discovery, Development, and Translation. http://id.loc.gov/authorities/names/no2007051854 has work: Public engagement and clinical trials (Text) https://id.oclc.org/worldcat/entity/E39PCFPdghJFG9MDDtWV4ytqHy https://id.oclc.org/worldcat/ontology/hasWork Print version: Public Engagement and Clinical Trials. Washington, D.C. : National Academies Press, ©2011 9780309219297 (OCoLC)767570602 FWS01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=400080 Volltext CBO01 ZDB-4-EBA FWS_PDA_EBA https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=400080 Volltext |
| spellingShingle | Public engagement and clinical trials : new models and disruptive technologies : workshop summary / Introduction -- Framing the problem -- Recruitment challenges in clinical trials for different diseases and conditions -- Models for public health engagement -- The media -- Novel clinical trial designs -- The health system's structure and culture -- Toward a patient-centered strategy for clinical trials. Clinical trials. http://id.loc.gov/authorities/subjects/sh85027069 Patient participation. http://id.loc.gov/authorities/subjects/sh97002539 Patient education. http://id.loc.gov/authorities/subjects/sh85098703 Clinical Trials as Topic Patient Participation Drug Evaluation Patient Education as Topic Études cliniques. Participation des patients. Éducation des patients. MEDICAL Laboratory Medicine. bisacsh Patient participation fast Patient education fast Clinical trials fast |
| subject_GND | http://id.loc.gov/authorities/subjects/sh85027069 http://id.loc.gov/authorities/subjects/sh97002539 http://id.loc.gov/authorities/subjects/sh85098703 |
| title | Public engagement and clinical trials : new models and disruptive technologies : workshop summary / |
| title_alt | Introduction -- Framing the problem -- Recruitment challenges in clinical trials for different diseases and conditions -- Models for public health engagement -- The media -- Novel clinical trial designs -- The health system's structure and culture -- Toward a patient-centered strategy for clinical trials. |
| title_auth | Public engagement and clinical trials : new models and disruptive technologies : workshop summary / |
| title_exact_search | Public engagement and clinical trials : new models and disruptive technologies : workshop summary / |
| title_full | Public engagement and clinical trials : new models and disruptive technologies : workshop summary / Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| title_fullStr | Public engagement and clinical trials : new models and disruptive technologies : workshop summary / Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| title_full_unstemmed | Public engagement and clinical trials : new models and disruptive technologies : workshop summary / Victoria Weisfeld, Rebecca A. English, and Anne B. Claiborne, rapporteurs ; Forum on Drug Discovery, Development, and Translation, Board on Health Sciences Policy, Institute of Medicine of the National Academies. |
| title_short | Public engagement and clinical trials : |
| title_sort | public engagement and clinical trials new models and disruptive technologies workshop summary |
| title_sub | new models and disruptive technologies : workshop summary / |
| topic | Clinical trials. http://id.loc.gov/authorities/subjects/sh85027069 Patient participation. http://id.loc.gov/authorities/subjects/sh97002539 Patient education. http://id.loc.gov/authorities/subjects/sh85098703 Clinical Trials as Topic Patient Participation Drug Evaluation Patient Education as Topic Études cliniques. Participation des patients. Éducation des patients. MEDICAL Laboratory Medicine. bisacsh Patient participation fast Patient education fast Clinical trials fast |
| topic_facet | Clinical trials. Patient participation. Patient education. Clinical Trials as Topic Patient Participation Drug Evaluation Patient Education as Topic United States Études cliniques. Participation des patients. Éducation des patients. MEDICAL Laboratory Medicine. Patient participation Patient education Clinical trials Electronic resource. |
| url | https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&AN=400080 |
| work_keys_str_mv | AT publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesmountsinaischoolofmedicine publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary AT weisfeldvictoriad publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary AT englishrebeccaa publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary AT claiborneanneb publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary AT instituteofmedicineusforumondrugdiscoverydevelopmentandtranslation publicengagementandclinicaltrialsnewmodelsanddisruptivetechnologiesworkshopsummary |